CTXR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Citius Pharmaceuticals Inc (CTXR) is not a good buy for a beginner investor with a long-term strategy at this time. The stock shows weak financial performance, no significant positive catalysts, and lacks strong trading signals. Additionally, the technical indicators and options sentiment do not support a strong bullish case.
The MACD is slightly positive but contracting, RSI is neutral at 48.135, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot level of 0.809, with key support at 0.716 and resistance at 0.903. The stock's recent price action shows a pre-market increase of 4.53% but a regular market drop of -11.78%, suggesting volatility and lack of stability.
No significant positive catalysts identified. The stock shows a potential 12.93% increase in the next month based on historical candlestick patterns, but this is speculative.
suggests uncertainty, and the stock has a 90% chance of declining in the short term.
In Q4 2025, revenue remained at 0 with no growth. Net income dropped significantly to -7.96M (-30.88% YoY), and EPS fell to -0.46 (-71.07% YoY). Gross margin remained at 0. The financials indicate poor performance and lack of growth.
No recent analyst ratings or price target updates available. Wall Street sentiment is neutral with no strong pros or cons identified.
